• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Enovis partners with Kelvi on hot and cold therapies

Enovis partners with Kelvi on hot and cold therapies

July 1, 2022 By Sean Whooley

Enovis and Kelvi logosEnovis, the parent company of DJO, announced that it entered into a strategic partnership with Kelvi for heating and cooling therapies.

Kelvi, which develops hot and cold therapy products, will work with Enovis to deliver industry-leading therapies for rehabilitation, recovery and performance enhancement for patients and athletes of all abilities. According to a news release, DJO (as part of Enovis) will become the exclusive distributor in the orthopedic market of Kelvi’s heating and cooling therapy products.

Kelvi offers a multimodal approach to heating and cooling. It’s developed “smart” KelviTEC technology that applies heating and cooling principles for medical and athletic recovery while also providing convenience for athletes, athletic trainers and medical technicians, coupled with high precision, tight temperature control, trackability and repeatability, Enovis said.

“As we expand and grow as a med-tech company, we are excited about the impact and potential of this partnership for our customers and patients,” Enovis VP of Marketing for Bracing and Supports Guy Guglielmino said in the release. “Kelvi products, powered by patented KelviTEC science, are ideally positioned to complement the Enovis mission of creating better together, borne from the belief that activity and movement are key to living a healthier lifestyle, better treatment outcomes, and improved healthcare economics for all.”

Enovis President of Bracing and Supports, Jason Anderson, added that the company’s “robust and best-in-class distribution capabilities” offers an exciting future when coupled with Kelvi’s technology. Kelvi CEO Julio Vergara said Enovis is a “perfect match” for its products.

“At Kelvi, we continue to revolutionize how thermotherapy is delivered — we spent more than seven years developing our innovative technology — and our next generation console, to be carried exclusively by Enovis for the orthopedic market, will optimize outcomes for athletes and post-operative patients,” Vergara said. “We are humbled by the journey, from our founders’ vision at UCLA through our collaboration with athletes and thought leaders. We are excited to partner with the innovation leader in our space, aligned with getting and keeping people moving. We look forward to being part of that.”

Filed Under: Business/Financial News, Featured, News Well, Orthopedics Tagged With: DJO, DJO Global, Enovis, Kelvi

More recent news

  • Sequel Med Tech’s automated twiist pump scores FDA clearance in type 2 diabetes
  • FDA posts alert for Edwards Lifesciences mitral valve delivery system after patient death
  • Former Medtronic RDN leader joins Teleflex
  • CMR Surgical CEO outlines the path forward for Stryker’s robotics partnership
  • Stryker earns FDA clearance for new bone and soft tissue removal platform

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy